HEMOGLOBINOPATHIES AMONG SAUDI ADULTS AT TAIF CITY, SAUDI ARABIA
https://doi.org/10.25837/HAT.2018.44..2..006
Abstract
Introduction. Hemoglobin variants can be either hemoglobinopathies which are responsible for diseases or non-pathological variants which couldn’t make any detectable disorder. Carriers with structural variant haemoglobin have 30 to 50% of the variant haemoglobin in their red blood cells. The most common variant hemoglobin is hemoglobin S, which accounts for 40% of carriers and responsible for more than 80% of disorders related to hemoglobinopathies. According to the World Health Organization (WHO) there are at least 948 000 new carrier couples, and over 1.7 million pregnancies to carrier couples every year. Thus, it is very important to provide a systematic carrier screening program specially among athigh risk couples. This might help to prevent or/and reduce the incidence of blood disorders that related to variant haemoglobin. The aim of this study was to assess the variant haemoglobin among Saudis who were attending the Centre of premarital screening.
Materials and methods. A total of 9008 blood samples were studied among Saudi male and female who were attending the Centre of premarital screening from January 2015 to October 2015 at Taif City. Samples were then analyzed by High Performance Liquid Chromatography.
Results. Abnormal haemoglobin fractions on HPLC were displayed in 118 cases. The result of this study showed that Hb S heterozygous was presented as the major abnormality with 58.5% followed by beta thalassemia minor with 21%.
Conclusion. Clear understanding the genetics and the prevalence of these diseases will provide opportunities for prevention or/and reduce the incidence. Thus, this study suggests that in addition to the huge efforts already accomplished by the Saudi Ministry of Health to prevent at-risk marriages, the early diagnosis for these disorders might be offered for young adults as they can discuss the issue in the early stage of the marriage proposal.
About the Authors
H. A. DahlawiSaudi Arabia
Haytham Ahmad Dahlawi
R. G. Zaini
Saudi Arabia
O. M. Zamzami
Saudi Arabia
A. F. Alhumyani
Saudi Arabia
References
1. Trent R. J. Diagnosis of the haemoglobinopathies. Clinical Biochemist Reviews 2006; 27:27—38.
2. Urbinati F., Madigan C., Malik P. Pathophysiology and therapy for haemoglobinopathies; Part II: thalassaemias. Expert Reviews in Molecular Medicine 2006; 8:1—26.
3. Angastiniotis M., Modell B. Global epidemiology of hemoglobin disorders. Annals of the New York Academy of Sciences 1998; 850:251—269.
4. Weatherall D., Clegg J. Distribution and population genetics of the thalassaemias // In: The Thalassaemia Syndromes, fourth edition. — WileyBlackwell, 2001; pp. 237—284.
5. Modell B., Darlison M., Birgens H. et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scandinavian Journal of Clinical and Laboratory Investigation 2007; 67:39—70.
6. Modell B., Harris R., Lane B. et al. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ 2000; 320:337—341. already accomplished by the Saudi Ministry of Health to prevent at-risk marriages through premarital screening program, the early diagnosis for these disorders might be offered for young individuals such as at the high school level and among at-high risk population. Subsequently, they can discuss the issue in the early stage of the marriage proposal.
7. AlHamdan N. A., AlMazrou Y. Y., AlSwaidi F. M. et al. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in Medicine 2007; 9:372—377.
8. Zaini R. G. Sickle-cell anemia and consanguinity among the Saudi Arabian population. Archives of Medicine 2016; 8:3.
9. Sachdev R., Dam A. R., Tyagi G. Detection of Hb variants and hemoglobinopathies in Indian population using HPLC: report of 2600 cases. Indian Journal of Pathology and Microbiology 2010; 53:57.
10. Alenazi S. A., Ali H. W., Alharbi M. G. et al. Prevalence of thalassemia and sickle cell disease in northern border region of Saudi Arabia. Kashmir J Med Sci 2015; 1:3—6.
11. Al-JaouniS.K. Prevalence of thalassemia disorders and hemoglobinopathies in Jeddah, Western Saudi Arabia. J Appl Hematol 2010; 1:43—46.
12. Memish Z. A., Saeedi M. Y. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Annals of Saudi Medicine 2011; 31:229.
Review
For citations:
Dahlawi H.A., Zaini R.G., Zamzami O.M., Alhumyani A.F. HEMOGLOBINOPATHIES AMONG SAUDI ADULTS AT TAIF CITY, SAUDI ARABIA. Russian journal of hematology and transfusiology. 2018;63(2):159-165. (In Russ.) https://doi.org/10.25837/HAT.2018.44..2..006